The Medicines Company to Announce Fourth Quarter and Full Year 2012 Financial Results on Wednesday, February 20, 2013

Conference Call to Be Held at 8:30 a.m. Eastern Time

(firmenpresse) - PARSIPPANY, NJ -- (Marketwire) -- 02/12/13 -- The Medicines Company (NASDAQ: MDCO) has scheduled its quarterly conference call for Wednesday, February 20 at 8:30 a.m. Eastern Time to discuss fourth quarter and full year 2012 financial results, operational developments, and outlook for 2013.

The conference call will be available via phone and webcast. The dial in information is listed below:

Domestic Dial In: 800 688 0836
International Dial In: 617 614 4072
Passcode for both dial in numbers: 77632519

Replay is available from 10:30 a.m. Eastern Time following the conference call through March 6, 2013. To hear a replay of the call dial 888 286 8010 (domestic) and 617 801 6888 (international). Passcode for both dial in numbers is 15572588.

This call is being webcast and can be accessed at The Medicines Company website at .

The Medicines Company (NASDAQ: MDCO) provides medical solutions to improve health outcomes for patients in acute and intensive care hospitals worldwide. These solutions comprise medicines and knowledge that directly impact the survival and well-being of critically ill patients. The Medicines Company's website is .





Contact:
Michael Mitchell
The Medicines Company
973-290-6000

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: MARKETWIRE
Datum: 12.02.2013 - 23:11 Uhr
Sprache: Deutsch
News-ID 228864
Anzahl Zeichen: 0

contact information:
Town:

PARSIPPANY, NJ

Kategorie:

Healthcare

Diese Pressemitteilung wurde bisher 245 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"The Medicines Company to Announce Fourth Quarter and Full Year 2012 Financial Results on Wednesday, February 20, 2013"
steht unter der journalistisch-redaktionellen Verantwortung von

The Medicines Company (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

The Medicines Company to Participate in Upcoming Investor Conference Webcasts ...

PARSIPPANY, NJ -- (Marketwired) -- 11/27/13 -- The Medicines Company (NASDAQ: MDCO) is scheduled to present at the 25th Annual Piper Jaffray Healthcare Conference on December 4th at 12:30 PM Eastern Time. MDCO is also scheduled to present at the Opp ...

European Medicines Agency Accepts Marketing Authorization Application for The Me ...

PARSIPPANY, NJ -- (Marketwired) -- 11/21/13 -- The Medicines Company (NASDAQ: MDCO) today announced that the European Medicines Agency (EMA) has accepted for review a marketing authorization application (MAA) for the investigational hemostatic agent ...

FDA Grants QIDP Designation to The Medicines Company's Investigational Anti ...

PARSIPPANY, NJ -- (Marketwired) -- 11/12/13 -- The Medicines Company (NASDAQ: MDCO) today announced that the U.S. Food and Drug Administration (FDA) has designated oritavancin as a Qualified Infectious Disease Product (QIDP). The QIDP designation pr ...

Alle Meldungen von The Medicines Company